Filing Details

Accession Number:
0001562180-19-002783
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-13 19:40:21
Reporting Period:
2019-05-09
Accepted Time:
2019-05-13 19:40:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1603756 Axonics Modulation Technologies Inc. AXNX Surgical & Medical Instruments & Apparatus (3841) 454744083
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1756399 Rinda Sama 26 Technology Drive
Irvine CA 92618
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-09 871 $1.42 4,871 No 4 M Indirect By Spouse
Common Stock Acquisiton 2019-05-09 1,225 $1.63 6,096 No 4 M Indirect By Spouse
Common Stock Acquisiton 2019-05-09 941 $1.32 7,037 No 4 M Indirect By Spouse
Common Stock Acquisiton 2019-05-09 480 $1.32 7,517 No 4 M Indirect By Spouse
Common Stock Acquisiton 2019-05-09 6,228 $0.98 13,745 No 4 M Indirect By Spouse
Common Stock Acquisiton 2019-05-09 1,800 $0.97 15,545 No 4 M Indirect By Spouse
Common Stock Acquisiton 2019-05-09 1,800 $0.97 17,345 No 4 M Indirect By Spouse
Common Stock Disposition 2019-05-09 13,345 $28.03 4,000 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect By Spouse
No 4 M Indirect By Spouse
No 4 M Indirect By Spouse
No 4 M Indirect By Spouse
No 4 M Indirect By Spouse
No 4 M Indirect By Spouse
No 4 M Indirect By Spouse
No 4 S Indirect By Spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to buy) Disposition 2019-05-09 871 $0.00 871 $1.42
Common Stock Stock Options (Right to buy) Disposition 2019-05-09 1,225 $0.00 1,225 $1.63
Common Stock Stock Options (Right to buy) Disposition 2019-05-09 941 $0.00 941 $1.32
Common Stock Stock Options (Right to buy) Disposition 2019-05-09 480 $0.00 480 $1.32
Common Stock Stock Options (Right to buy) Disposition 2019-05-09 6,228 $0.00 6,228 $0.98
Common Stock Stock Options (Right to buy) Disposition 2019-05-09 1,800 $0.00 1,800 $0.97
Common Stock Stock Options (Right to buy) Disposition 2019-05-09 1,800 $0.00 1,800 $0.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,021 2027-08-25 No 4 M Indirect
2,975 2028-03-30 No 4 M Indirect
929 2027-05-22 No 4 M Indirect
560 2027-07-05 No 4 M Indirect
1,244 2026-01-15 No 4 M Indirect
0 2024-06-29 No 4 M Indirect
0 2025-04-01 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 220,627 Direct
Footnotes
  1. The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.91 to $28.17, inclusive. The reporting person undertakes to provide Axonics Modulation Technologies, Inc., any security holder of Axonics Modulation Technologies, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 21, 2018 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 21, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
  3. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2019 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
  4. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on May 23, 2018 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of May 23, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
  5. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 5, 2017 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 5, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
  6. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on January 15, 2017 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of January 15, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
  7. he shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on June 30, 2015 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of June 30, 2015, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
  8. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on April 2, 2016 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of April 2, 2016, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.